β-Adrenergic receptor polymorphisms: relationship to the β-agonist controversy and clinical implications
- 26 November 2007
- journal article
- review article
- Published by Taylor & Francis in Expert Opinion on Pharmacotherapy
- Vol. 8 (18) , 3195-3203
Abstract
(2007). β-Adrenergic receptor polymorphisms: relationship to the β-agonist controversy and clinical implications. Expert Opinion on Pharmacotherapy: Vol. 8, No. 18, pp. 3195-3203. doi: 10.1517/14656566.8.18.3195Keywords
This publication has 45 references indexed in Scilit:
- Sequence, Haplotype, and Association Analysis of ADRβ2 in a Multiethnic Asthma Case-Control StudyAmerican Journal of Respiratory and Critical Care Medicine, 2006
- Arginine-16 2 adrenoceptor genotype predisposes to exacerbations in young asthmatics taking regular salmeterolThorax, 2006
- Overview of the pharmacogenetics of asthma treatmentThe Pharmacogenomics Journal, 2006
- β2 Déjà VuChest, 2006
- Systematic Review and Meta-Analysis of the Association between β2-Adrenoceptor Polymorphisms and Asthma: A HuGE ReviewAmerican Journal of Epidemiology, 2005
- Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trialThe Lancet, 2004
- Adverse effects of short‐acting beta‐agonists: Potential impact when anti‐inflammatory therapy is inadequateRespirology, 2004
- Pharmacology and Physiology of Human Adrenergic Receptor polymorphismsAnnual Review of Pharmacology and Toxicology, 2003
- The ??2-Agonist ControversyDrug Safety, 1994
- Asthma induced by adrenergic aerosolsJournal of Allergy, 1970